2022
- Kuntz T, Siebdrath J, Hofmann SC, Baltaci M, Schaller J, Hellmich M, von Goltzheim LS, Assaf C, Oellig F, Michalowitz AL, Helbig D, Kreuter A. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers. J Dtsch Dermatol Ges. 2022 Nov 28. doi: 10.1111/ddg.14911. Online ahead of print.
- Webster JF, Beerens S, Wozny C (2022) Effects of early life stress and subsequent re-exposure to stress on neuronal activity in the lateral habenula. Neuropsychopharmacology. doi: 10.1038/s41386-022-01493-0.
- Michalowitz AL, Burmann SN, Oellig F, Assaf C, Cerroni L, Kreuter A.Bendamustine monochemotherapy in aggressive or advanced-stage primary cutaneous T-cell lymphomas. J Eur Acad Dermatol Venereol. 2022 Oct 26. doi: 10.1111/jdv.18691. Online ahead of print.
- Felbor U, Bülow R, Schmutzler RK, Rath M. Hereditary Breast and Ovarian Cancer Service in Sparsely Populated Western Pomerania. Healthcare (Basel). 2022 Oct 13; 10(10). doi:10.3390/healthcare10102021.
- Oymanns M, Daum-Marzian M, Bellm A, Elsayad K, Eich HT, Assaf C. Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced CTCL. Br J Dermatol. 2022 Oct 20. doi.org/10.1093/bjd/ljac012
- He H, Stauber T, Liao W, Jiang Y, Yu Y, Peng J. Editorial: Ion channels and transporters in epilepsy: From genes and mechanisms to disease-targeted therapies. Front Mol Neurosci. 2022 Sep 21;15:1011843. doi: 10.3389/fnmol.2022.1011843.
- Langrich T, Bork K, Horstkorte R, Weber V, Hofmann B, Fuszard M, Olzscha H (2022) Disturbance of Key Cellular Subproteomes upon Propofol Treatment Is Associated with Increased Permeability of the Blood-Brain Barrier. Proteomes. doi: 10.3390/proteomes10030028.
- Blazejak C, Stranzenbach R, Gosman J, Gambichler T, Wehkamp U, Stendel S, Klemke CD, Wobser M, Olk J, Nicolay JP, Weyermann M, Stadler R, Assaf C. Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network. Dermatology. 2022;238(3):498-506.
- Querfeld C, Scarisbrick JJ, Assaf C, Guenova E, Bagot M, Ortiz-Romero PL, Quaglino P, Bonizzoni E, Hodak E. Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides. Dermatology. 2022;238(2):347-357
- Assaf C, Dobos G. New treatment concepts and combination therapies for cutaneous T-cell lymphomas Dermatologie (Heidelb). 2022 Sep 8. doi: 10.1007/s00105-022-05053-x.
- Pilz RA, Skowronek D, Hamed M, Weise A, Mangold E, Radbruch A, Pietsch T, Felbor U, Rath M. Using CRISPR/Cas9 genome editing in human iPSCs for deciphering the pathogenicity of a novel CCM1 transcription start site deletion. Front Mol Biosci. 2022 Aug 25; 9:953048. doi:10.3389/fmolb.2022.953048.
- Model MA, Hassani Nia F, Zook E, Hollembeak JE, Stauber T. Uptake of Fluorescein upon Osmotic Cell Swelling is Dependent on the Volume-Regulated Anion Channel VRAC/LRRC8. PPExMed 2022;1:3-14. doi: 10.33594/000000533.
- Shoubash L, Baldauf J, Matthes M, Kirsch M, Rath M, Felbor U, Schroeder HWS. Long-term outcome and quality of life after CNS cavernoma resection: eloquent vs. non-eloquent areas. Neurosurg Rev. 2022 Jun 23; 45(1):649-660. doi:10.1007/s10143-021-01572-8.
- Rath M*, Schwefel K*, Malinverno M, Skowronek D, Leopoldi A, Pilz RA, Biedenweg D, Bekeschus S, Penninger JM, Dejana E, Felbor U. Contact-dependent signaling triggers tumor-like proliferation of CCM3 knockout endothelial cells in co-culture with wild-type cells. Cell Mol Life Sci. 2022 Jun 4; 79(6):340. doi:10.1007/s00018-022-04355-6. * equal contribution
- Reichelt-Wurm S, Pregler M, Wirtz T, Kretz M, Holler K, Banas B, Banas MC. The Interplay of NEAT1 and miR-339-5p Influences on Mesangial Gene Expression and Function in Various Diabetic-Associated Injury Models. Noncoding RNA. 2022. 8(4), 52.
- Assaf C, Dobos G, Zech IM, Doess A, Hibbe T, Jadasz JJ. Care structure of patients with mycosis fungoides and Sézary syndrome in Germany - Care research based on SHI claims data. J Dtsch Dermatol Ges. 2022 May;20(5):643-651. doi: 10.1111/ddg.14725.
- Assaf C, Booken N, Dippel E, Guenova E, Jonak C, Klemke CD, Nicolay JP, Schlaak M, Wobser M, Trautinger F. The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region). J Dtsch Dermatol Ges. 2022 May;20(5):579-586. doi: 10.1111/ddg.14688.
- Beerens S, Winterer J, Lukacsovich D, Földy C, Wozny C. Transcriptomically-Guided Pharmacological Experiments in Neocortical and Hippocampal NPY-Positive GABAergic Interneurons. eNeuro. 2022 Apr 25;9(2):ENEURO.0005-22.2022. doi: 10.1523/ENEURO.0005-22.2022.
- Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Bernreiter S, Cozzio A, Eich HT, Elsayad K, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Loquai C, Meiss F, Mitteldorf C, Wehkamp U, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stranzenbach R, Moritz R, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021. J Dtsch Dermatol Ges. 2022 Apr;20(4):537-554.
- Nawar T, Elsayad K, Müller EC, Rolf D, Moritz RKC, Bormann E, Weishaupt C, Stranzenbach R, Stadler R, Moustakis C, Assaf C, Livingstone E, Sunderkötter C, Steinbrink K, Eich HT. Quality of life in patients with mycosis fungoides and Sézary syndrome undergoing low-dose total skin electron beam therapy with or without maintenance therapy. J Am Acad Dermatol. 2022 Apr;86(4):889-891
- Byrne AB, Brouillard P, Sutton DL, …, Rath M, …, Vikkula M, Scott HS, Harvey NL. Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema. Sci Transl Med. 2022 Mar 2; 14(634):eabm4869. doi:10.1126/scitranslmed.abm4869.
- Dobos G, Assaf C. Transcriptomic changes during stage progression of mycosis fungoides: from translational analyses to their potential clinical implications. Br J Dermatol. 2022 Mar;186(3):387-388
- Moudio S, Willis A, Pytka K, Abulkassim R, Brett RR, Webster JF, Wozny C, Barbour M, Jiang HR, Watson DG, van Kralingen JC, MacKenzie SM, Daniels M, McColl BW, Sossick S, Nuthall HN, Bushell TJ. Protease-activated receptor 2 activation induces behavioural changes associated with depression-like behaviour through microglial-independent modulation of inflammatory cytokines. Psychopharmacology (Berl). 2022 Jan;239(1):229-242. doi: 10.1007/s00213-021-06040-1.